Since the global roll-out of COVID-19 injections in late 2020, significant data has emerged linking them to a concerning number of deaths.
Epidemiologist and Foundation Administrator at McCullough Foundation, Nicolas Hulscher, MPH highlighted findings suggesting that the death toll from these vaccines could be staggering.
Research by Rancourt et al. estimated that 17 million COVID-19 vaccine deaths occurred worldwide by September 2023. Additionally, Mostert et al. reported 3.1 million excess deaths attributed to vaccination and lockdowns across 47 Western countries from 2020 to 2022.
The Vaccine Adverse Event Reporting System (VAERS) recorded 37,966 reported COVID-19 vaccine deaths. An under-reporting factor of 31 suggests a potential total of 1,176,946 vaccine-related deaths in countries utilizing VAERS.
Furthermore, Skidmore estimated that 278,000 Americans may have died from the COVID-19 vaccine by December 2021. In another study, Pantazatos and Seligmann indicated a possible 146,000 to 187,000 vaccine-associated deaths in the U.S. by August 2021.
Hulscher’s own research points to alarming trends, estimating 49,240 excess cardiac arrest deaths potentially linked to COVID-19 vaccination in the U.S. from 2021 to 2023. Analysis of 325 autopsies revealed a high likelihood of a causal link between COVID-19 vaccines and mortality.
Other studies indicate a correlation between higher vaccine uptake and increased all-cause mortality. Alessandria et al. found that vaccinated individuals had a higher risk of death compared to unvaccinated individuals, with those receiving two doses losing 37% of life expectancy during follow-up.
Regardless of the methodology, these estimates suggest a troubling number of suspected deaths resulting from the COVID-19 injections. To provide context, approximately 140,000 individuals were killed in the atomic bombing of Hiroshima in 1945. This means the COVID-19 vaccination campaign could equate to over 121 Hiroshima nuclear attacks in terms of potential deaths.
Federal agencies’ eventual acknowledgment of COVID-19 vaccine-related deaths may parallel the slow recognition of the harms of smoking, which took decades to accept. Historical data show that between 1953 and 2013, 462 medicinal products were withdrawn from the market, typically years after the first reports of adverse reactions.
The FDA defines a Class I recall as a situation with a reasonable probability that a product will cause serious health consequences or death. This definition suggests that an immediate Class I recall of COVID-19 injectable products is necessary to protect public safety.
The continuation of promoting these medical products raises serious ethical concerns under The Precautionary Principle. As Hulscher emphasizes, the next presidential administration should prioritize the immediate safety of the U.S. population, particularly those aged six months and older.